NDRA
Healthcare Diagnostics & ResearchENDRA Life Sciences Inc.
$6.04
-0.25 -3.97% today
Price History
Not enough data
Key Stats
Market Cap
9.06M
Avg Volume
36,260
EPS
-$6.26
52W High
$9.85
52W Low
$2.96
Div. Yield
0.0%
Valuation
Forward P/E
-1.99
P/B Ratio
1.44
EV/EBITDA
-1.23
Margins
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
EBITDA Margin 0.0%
Growth & Returns
Return on Equity
(152.0%)
Return on Assets
(77.3%)
Liquidity & Leverage
Current Ratio
7.10
Quick Ratio
2.21
Debt / Equity
0.07
Total Cash
1.74M
Total Debt
429,274
About
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
endrainc.com